Skip to main
  1. Stocks
  2. Newamsterdam Pharma Co NV
  3. Market Cap
NAMS

NAMS Market Capitalization Overview

Market Cap: $2.49B as of Oct 29, 2026

$2.49B
$364.59M (12.81%)past month
As of Oct 29, 2026, NAMS has a market capitalization of $2.49B. Over the past 30 days, its market cap has decreased by -3.05%, while in the last 12 months, it has decreased by -37.61%.

Market capitalization represents the total value of Newamsterdam Pharma Co NV as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NAMS Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NAMS helps investors assess the company's size and compare it with competitors for better investment decisions.

NAMS Market Cap & Key Trends

See Newamsterdam Pharma Co NV’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in NAMS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NAMS Market Cap History

DateMarket CapChange
Oct 1, 2026$2.89B-3.05%
Sep 1, 2026$2.98B-7.31%
Aug 3, 2026$3.22B-21.84%
Jul 1, 2026$4.12B+10.63%
Jun 1, 2026$3.72B+11.82%
May 1, 2026$3.33B-11.90%
Apr 1, 2026$3.78B-0.06%
Mar 2, 2026$3.78B+5.44%
Feb 2, 2026$3.58B-10.31%
Jan 2, 2026$3.99B-11.13%

NAMS End of Year Market Cap History

DateMarket CapChange
2026$2.49B-37.61%
2025$3.98B+44.88%
2024$2.75B+198.58%
2023$919.57M+375.26%
2022$193.49M+11.79%
2021$173.08M—

FAQs About Newamsterdam Pharma Co NV (NAMS) Market Cap

As of Oct 29, 2026, the market capitalization of NAMS is $2.49B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Newamsterdam Pharma Co NV’s market capitalization has decreased by -12.81%, changing from $2.85B to $2.49B as of Oct 29, 2026.

In the last 3 months, Newamsterdam Pharma Co NV’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Newamsterdam Pharma Co NV’s market capitalization increased from $2.75B in January to $3.98B in December, reflecting a 44.88% change.

In the past five years, NAMS has had a compound annual growth rate (CAGR) of 87.19% in market capitalization. This means its market cap has grown at an average rate of 87.19% per year.

Newamsterdam Pharma Co NV (NAMS)


NAMS Market Cap & Key Trends

See Newamsterdam Pharma Co NV’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in NAMS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NAMS stock data and trends